INTRODUCTION
Pulsatile system is amongst one of them and gaining a lot of interest as it is increasing patient compliance by means of providing time-and site-specific drugdelivery system, thus providing special Pulsed or pulsatile drug release is defined as the rapid and transient release of a certain amount of drug molecules within a short time-period immediately after a predetermined off-release period 1 . Pulsatile release is commonly found in the body, for example during hormone release, in which a baseline release is combined with pulsed, one-shot type release within a short time rangeand temporal delivery. A pharmaceutical dosage form such as a capsule capable of delivering therapeutic agents into the body in a timecontrolled or position-controlled pulsatile release fashion, is composed of a multitude of multicoated particulates (beads, pellets,granules, etc.) made of one or more populations of beads. On which cases or circumstance pulsatile drug delivery is used they are listed below. 1) Chronopharmacotherapy of diseases which shows circadian rhythms in their pathophysiology.
2) Avoiding the first pass metabolism e.g. protein and peptides 2 3) For which the tolerance is rapidly exists, 4) For targetting specific site in intestine e.g. colon, 5) For time programmed administration of hormone and drugs, 6) For drugs having the short half life and their mechanism.
Drugs which exhibit tolerance that drugs not be delivered at a constant rate, since the drug effect decreases with time at constant drug level. The drug toxicity increases with time. In such cases it is preferable for dosage form which will provide desired concentration of drug at particular time point only. Now the concept of chronopharmaceutics has emerged, where is research devoted to the design and evaluation of drug delivery systems that release a therapeutic agent at a rhythm that ideally matches the biological requirement of a given disease therapy. "Chronopharmaceutics" consist of two words chronobiology and pharmaceutics. Chronobiology is the study of biological rhythms. There are three types of mechanical rhythms in our body. Circadian This word comes from Latin word "circa" means about and "dies" means day Ultrdian Oscillation of shorter duration is called as ultradian (more than one cycle per 24 h ) Infradian Oscillations that are longer than 24 h (less than one cycle per day). Diseases where a constant levels of drug the are not preferred, but needs a pulse of therapeutic concentration in a periodic manner acts as a push for development of "Pulsatile Drug Delivery Systems "4.
MERITS

:
Predictable, reproducible and short gastric residence time
Less inter-and intra-subject variability Improve bioavailability 1. First pass metabolism:
Some drugs, such as beta blockers, and salicylamide, undergo extensive first pass metabolism and require fast drug input to saturatemetabolizing enzymes in order to minimize pre-systemic metabolism. Thus, a constant/sustained oral method of delivery would result in reduced oral bioavailability.
Biological tolerance:
Drug plasma profiles are explain by a decline in the pharmacotherapeutic effect of the drug, e.g., biological tolerance of transdermal nitroglycerin, salbutamol sulphate.
Special chronopharmacological needs:
Circadian rhythms in certain physiological functions are well established. It has been recognized that many symptoms and onset of disease occur during specific time periods of the 24 hour day, e.g., asthma and angina pectoris attacks are most frequently in the morning hours.
Local therapeutic need:
For the treatment of local disorders such as inflammatory disease, the delivery of compounds to the site of inflammation with no loss due to absorption in the small intestine is highly desirable to achieve the therapeutic effect and to minimize side effects.
Gastric irritation or drug instability in gastric fluid:
Protection for those drugs are essential which are effected by gastric acidic environment and undergo degradation in gastric acidic medium (eg, peptide drugs), irritate the gastric mucosa (NSAIDS) or induce nausea and vomiting.
Classification of pulsatile drug delivery systems 6, 7 Pulsatile drug delivery systems (PDDS) is classified in two systems one is site-specific and other is timecontrolled systems. Drug release from site-specific systems depends on the environment in the gastro intestinal track, e.g., on pH, presence of enzymes etc. In contrast, time-controlled DDS are independent of the biological environment. The drug release is controlled only by the system. Time-controlled pulsatile delivery has been achieved mainly with drug containing cores, which are covered with release-controlling layers 
TIME-CONTROLLED SYSTEM
Time-dependent dosage forms are those dosage forms which are formulated to release their drug load after a predetermined lag time. To achieve a drug release that is independent of the environment (e.g. pH, enzymatic activity, intestinal motility) and/or other stimuli, the lag time prior to the release of the drug has to be controlled primarily by the delivery system 8 . The release mechanisms employed include bulk erosion of polymers in which drug release by diffusion is restricted, surface erosion of layered devices composed of alternating drug-containing and drug-free layers, and osmotically controlled rupture 9 .
SITE-SPECIFIC SYSTEM
colon specific dosage forms have been developed including pro-drugs, drug embedded in cross-linked hydrogel delivery of drugs to the colon can be done to achieve many objectives like reduction in dosing frequency, to deliver drug to a region that is less hostile metabolically efficacy of the drug generally depends upon the ability of the drug to reach its target in sufficient quantity to maintain therapeutic levels for the desired time period . Although, the colon does not inherently possess the ideal anatomical and physiological features, it is the site of significant absorption. etc 10 . Other commercial benefits can be the ever-greening of already existing patents and the ability to promote new claims. In the past few years many matrices, coated dosage forms, osmotic controlled drug delivery systems and timed release systems. The coated dosage forms are preferred because of innovations in the coating technology and wide flexibility in the design 11 . A study on several examples for both single and multiple unit gastroretentive drug delivery systems has been done by Streubel et al 12 The rationale of drug targeting to the colon which we would be focusing on in this review is to delay delivery to a time appropriate to treat acute phases of a disease i.e., to achieve a chronotherapeutic drug delivery response.
TIME CONTROLE SYSTEM
A. SINGLE UNIT SYSTEM
These are sub-classified as capsule-based systems, osmotic systems.Delivery systems with soluble or erodible membranes and delivery systems with rupturable coating.
(i) TABLET SYSTEM
Most of the pulsatile drug delivery systems are reservoir devices coated with a barrier layer. This barrier erodes or dissolves after a specific lag period, and the drug is subsequently released rapidly. The lag time depends on the thickness of the coating layer.
(ii) CAPSULAR SYSTEM
Single unit systems are mostly developed in capsule form. The lag time is continued by a plug, which gets pushed away by swelling or erosion, and the drug is released as a pulse from the insoluble capsule body. e.g.: Pulsincap® system In this system a water insoluble body containing the drug formulation, system is closed with a swellable hydrogel. Plugged (insoluble but permeable &swellable) at open end. For rapid release of water insoluble drug effervescent or disintegrating agents are added 13 .
(iii) PULSATILE DELIVERY BY OSMOSIS
This system consists of a capsule coated with a semi permeable membrane. Inside the capsule the drug formulation. This system shows good invivo and invitro correlation in humans and used to deliver methylphenidate to school age children for the treatment of Attention Deficit Hyper activity Disorder (ADHD), e.g.: Port® System Another system is also based on expendable orifice that contain capsular system in which liquid drug is absorbed on highly porous particles. Drug releases through orifice of a semi permeable capsule supported by an expending osmotic layer after the barrier layer is dissolved 15 . The Port® System (Port Systems, LLC) consists of a gelatin capsule coated with a semi permeable membrane (e.g., cellulose acetate) housing an insoluble plug (e.g., lipidic) and an osmotically active agent.
EROSION OF MEMBRANE
These systems are based up on a drug reservoir surrounded with a soluble or erodible barrier layer that dissolves with time and the drug releases at once after the lag time. E.g. Time Clock® system. The Time Clock system consists of solid dosage form coated with lipid barriers such as carnauba wax & beeswax along with surfactants like polyoxy ethylene sorbinmono oleate. When this system comes in contact with the aqueous medium the coat emulsifies or erodes after the lag-time depending on the thickness of coat.The lag time of system independent of the gastrointestinal motility, PH, enzyme & gastric residence 16 .
(v) PULSATILE DELIVERY BY RUPTURE OF MEMBRANE
These systems are based up on a reservoir system coated with a rupturable membrane. The outer membrane ruptures due to the pressure developed by effervescent agents (or) swelling agent 17 . Citric acid & sodium bicarbonate is incorporated as effervescent mixture in tablet core coated with ethyl cellulose, when system comes in contact with water it produces carbon dioxide gas which exerts pressure & after lag time rupture the membrane & rapid release of drug occurs . A reservoir system with a semi permeable coating is proposed especially with drugs with high first pass effect in order to obtain in-vivo drug pattern similar to the administration of several immediate release doses croscarmellose sodium starch glycollate or low substituted hydroxy propyl cellulose were used as swelling substances, which resulted in complete film rupture followed by rapid drug release. The lag time is controlled by composition of outer polymeric membrane.
B. MULTIPAL UNIT SYSTEMS
Multiparticulate systems are reservoir type of devices with a coating, which either ruptures or changes its permeability. Drug is coated over sugar seeds these granules may then be packaged in a capsule or compressed with additional excipients to form a tablet. The active pharmaceutical ingredient may also be blended or granulated with polymers before coating to provide an additional level of control. However, drug loading in this type of system is low due to higher need of excipients.
(i) PULSATILE DELIVERY BY RUPTURABLE COATING
Similar to single unit system, the rupturing effect is achieved by coating the individual units with effervescent (or) swelling agents. Drug deliver was controlled by the rupture of the membrane. The timing of release was controlled by the thickness of coating and the amount of water soluble polymer to achieve the pulsed release. The swelling agent includes super disintegrents like carboxymethylcellulose, sodium starch glycollate, and Lhydroxy propyl cellulose. Polymers like polyacrylic acid, polyethylene glycol etc. alternatively comprising of a mixture of tartaric acid & sodium bicarbonate that used as effervescent agent 18 . The lag time is controlled by composition of outer polymeric membrane.
METHODOLOGIES FOR PULSATILE DRUG DELIVERY SYSTEM
Methodologies for the pulsatile drug delivery system can be broadly classified into three classes: 
TIME CONTROLLED PULSATILE RELEASE SYSTEM
In time controlled drug delivery systems pulsatile release is obtained after a specific time interval in order to mimic the circadian rhythm. Such type of pulsatile drug delivery system contains two Components: one is of immediate release type and other one is a pulsed release type. Various methodologies that can be used for time controlledpulsatile release systems are discussed in following section.
(i) Delivery systems with rupturable coating layer
These systems consist of an outer release controlling water insoluble but permeable coating subject to mechanically induced rupture phenomenon. Recently different systems based on hard gelatin capsules, all coated by inner swellable and outer rutpurable layer. The film rupture may be attained by including swelling, osmotic oreffervescent additives in the reservoir. By optimizing the system, drug release can be obtained at specific time interval. In such systems the drug release is controlled by the dissolution or erosion of the outer coat which is applied on the core containing drug. Time dependent release of the active ingredient can be obtained by optimizing the thickness of the outer coat. Sangalliet al. developed an oral dosage form devised to release drugs following a programmed time period after administration based on this concept.
(iii) Capsule shaped system provided with release controlling plug
These systems contain release controlling plug between immediate release compartment and pulsed release compartment. On contact with aqueous fluids, the cap rapidly dissolves thereby releasing the immediate release component followed by pulsed release component. The lag time is provided by the plug which is inserted in to the body. In an approach used by Jimoh et al, pulsatile release was achieved by generation of hydrostatic pressure inside the capsule.
STIMULI INDUCED PULSATILE SYSTEMS
In these systems there is release of the drug after stimulation by any biological factor like temperature, or any other chemical stimuli. These systems are further classified in to temperature induced systems and chemical stimuli induced system, on the basis of stimulus.
(i) Temparature induced systems
Thermo-responsive hydrogel systems have been developed for pulsatile release. In these systems thepolymer undergoes swelling or deswelling phase in response to the temperature which modulate drug release in swollen state 18 . Y.H. Bae et al developed indomethacin pulsatile release pattern in the temperature ranges between 200C and 300C by using reversible swelling properties of copolymers of N-isopropylacrylamide and butyrylacrylamide. Kataokaet al developed the thermo sensitive polymeric micelles as drug carrier to treat the cancer.
(ii) Chemical stimuli induced pulsatile systems (a) Glucose-responsive insulin release devices
In case of diabetes mellitus there is rhythmic increase in the levels of glucose in the body requiring injection of the insulin at proper time. Several systems have been developed which are able to respond to changes in glucose concentration. One such system includes pH sensitive hydrogel containing glucose oxidase immobilized in the hydrogel. When glucose concentration in the blood increases glucose oxidase converts glucose into gluconic acid which changes the pH of the system. This pH change induces swelling of the polymer which results in insulin release. Insulin by virtue of its action reduces blood glucose level and consequently gluconic acid level also gets decreased and system turns to the deswelling mode thereby decreasing the insulin release. Examples of the pH sensitive polymers includes N,Ndimethylaminoethylmethacrylate. On receiving any physical or chemical stress, such as injury, fracture etc., inflammation take place at the injured sites.During inflammation, hydroxyl radicals are produced from these inflammation-responsive cells. Yui and co-workers focused on the inflammatory inducedhydroxyl radicals and designed drug delivery systems, which responded to the hydroxyl radicalsand degraded in a limited manner.
(c) Drug releasefrom intelligent gels responding to antibody concentration
There are numerous kinds of bioactive compounds which exist in the body. Recently, novel gels were developed which responded to the change in concentration of bioactive compounds to alter their swelling/deswelling characteristics. Special attention was given to antigenantibody complex formation as the cross-linking units in the gel, since such interaction is very specific.
(d) PH sensitive drug delivery system
Such type of pulsatile drug delivery system contains two components one is of immediate release type and other one is pulsed release which releases the drug in response to change in pH. In case of pH dependent system advantage has been taken of the fact that there exists different pH environment at different parts of the gastrointestinal tract. By selecting the pH dependent polymers drug release at specific location can be obtained. An example of pH dependent polymers includes cellulose acetate phthalate,polyacrylates, and sodiumcarboxymethylcellulose. Externally regulated systems for releasing the drug in a pulsatile manner, another way can be the externally regulated systems in which drug release is programmed by external stimuli likemagnetism, ultrasound, electrical effect and irradiation.Magnetically regulated systems contain magnetic beads in the implant. On application of the magnetic field, drug release occurs because of magnetic beads.
(iii) Magnetic stimuli-induced pulsatile release
Use of an oscillating magnetic held to regulate the rates of drug delivery from a polymer matrix was one of the first methodologies investigated to achieve an externally controlled drug delivery system. Magnetic steel beads were engrafted in an ethylene and vinyl acetate (EVAc) copolymermatrix that was loaded with bovine serum albumin as a model drug. Edelman and coworkersproved increased rates of drug release in the presence of an oscillating magnetic field.The beads oscillate within the matrix on exposure to the magnetic field, alternatively creatingcompressive and tensile forces. This in turn acts as a pump to push more amount of the activesolute out of the matrix. Co-polymers having higher Young's modulus were more resistant tothe induced motion of steel beads, and accordingly the magnetic held has less effect onthe rate of drug release from these materials. Saslawski and co-workers prepared various formulations for in vitro magnetically induced pulsatile delivery of insulin based on alginate spheres. In an experiment, ferrite microparticles (1 µm) and insulin powder were dispersed in sodium alginate aqueous solution.
(iv) Pulsatile system based on osmosis
The delivery of agents from osmotic systems is based on expandable orifice technology was developed. This system is in the form of capsule with an orifice.The capsule wall is constructed of an elastic material (e.g., styrene-butadiene copolymer), and stretches under a pressure differential caused by the pressure rise inside the capsule due to osmotic infusion of moisture from the body. When this elastic wall is stretched, because of pressure differential across the wall, exceeding a threshold, the orifice expands sufficiently to allow the release of the drug at a physiologically required rate. However, when the elastic wall is relaxed, the flow rate of the drug through the orifice is substantially zero.
(v) Thermoresponsive hydrogel systems:
Thermo-responsive hydrogel systems employ hydrogels which undergo reversible volume changes in response to changes in temperature. These gels shrink at a transition temperature that is referred to the lower critical solution temperature (LCST) of the linear polymer. Thermosensitive hydrosensitive hydrogels have a certain chemical attraction for water, and therefore they absorb water and swell at temperatures below the transition temperature whereas they shrink or deswell at temperatures above the transition temperature by expelling water. Thermally responsive hydrogels and membranes have been extensively exploited as platforms for the pulsatile drug delivery 20 .
(vi) Thermoresponsive polymeric micelle systems:
In this type, the gel system tightly stores targeted drug in the micelles and rapidly releases controlled amount of the drug by switching on-off of external stimuli such as temperature or infrared laser beam. Jianxiang Zhang, et al synthesized thermally responsive amphiphilicpoly(N isopropylacrylamide) (PNIPAm)-graftedpolyphosphazene (PNIPAm-g-PPP) by stepwise cosubstitution of chlorine atoms on polymer backbones with amino-terminated NIPAm oligomers and ethyl glycinate(GlyEt). Diflunisal (DIF)-loaded micelles were prepared by dialysis method. In vitro release test at various temperatures was also performed to study the effect of temperature on the drug release profiles.
(vii) EnzymaticaIIy-activated Liposome:
Drug loaded liposomes was incorporated into microcapsules of alginate hydrogels. Liposomes inside the microcapsules were coated with phospholipase A2 to achieve a pulsatile release of drug molecules. Phospholipase A2 was shown to accumulate at the water/liposome interfaces and remove an acyl group from the phospholipids in the liposome. Destabilised liposomes release their drug molecules, thus allowing drug release to be regulated by the rate determining microcapsule membrane 21, 22 .
Externally regulated pulsatile release system:
This system is not self-operated, but instead requires externally generated environmental changes to initiate drug delivery. These can include magnetic fields, ultrasound, electric field, light, and mechanical force.
(i) Magnetic induces release:
Magnetic carriers receive their magnetic response to a magnetic field from incorporated materials such as magnetite, iron, nickel, cobalt etc. Magnetic-sensitive behavior for controlled release of drug was studied by Tingyu Liu, et al. An intelligent magnetic hydrogel (ferrogel) was fabricated by mixing poly (vinyl alcohol) (PVA) hydrogels and Fe3O4 magnetic particles through freezing-thawing Cycles 23 . Although the external direct current magnetic field was applied to the ferrogel, the drug got accumulated around the ferrogel, but the accumulated drug spurt to the environment instantly when the magnetic fields instantly switched "off". Furthermore, rapid slow drug release can be tunable while the magnetic field was switched from "off" to "on" mode. The drug release behavior from the ferrogel is strongly dominated by the particle size of Fe3O4 under a given magnetic field 24 .Tingyu Liu, et al developed the magnetic hydrogels which was successfully fabricated by chemically crosslinking of gelatin hydrogels and Fe3O4 nanoparticles (ca. 40-60 nm) through genipin (GP) as cross-linking agent.
(ii) Ultrasound induces release:
Ultrasound is mostly used as an enhancer for the improvement of drug permeation through biological barriers, such as skin. The interactions of ultrasound with biological tissues is divided into two broad categories: thermal and nonthermal effects. Thermal effects are associated with the absorption of acoustic energy by the fluids or tissues 26 . Non-thermal bio-effects are generally associated with oscillating orcavitating bubbles, but also include noncavitation effects such as radiation pressure, radiation torque, and acoustic streaming.
(iii) Electric field induces release:
Electrically responsive delivery systems are prepared by polyelectrolytes (polymers which contain relatively high concentration of ionisable groups along the backbone chain) and are thus, pH-responsive as well as electroresponsive. Under the influence of electric field, electroresponsive hydrogels generally bend, depending on the shape of the gel which lies parallel to the electrodes whereas deswelling occurs when the hydrogel lies perpendicular to the electrodes.
(iv) Light induces release:
Light-sensitive hydrogels have potential applications in developing optical switches, display units, and opthalmic drug delivery devices 27 . The interaction between light and material can be used to modulate drug delivery. When hydrogel absorb the light and convert it to heat, raising the temperature of composite hydrogel above its LCST41, hydrogel collapses and result in an increased rate of release of soluble drug held within the matrix.
Multipaticulate system:
Recent trends indicate that multiparticulate drug delivery systems are especially suitable for achieving controlled or delayed release oral formulations with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. Such systems are reservoir type with either rupturable or altered permeability coating and generally housed in capsular body. The purpose of designing multiparticulate dosage form is to develop a reliable formulation that has all the advantages of a single unit formulation and yet devoid of the danger of alteration in drug release profile and formulation behaviourdueto unit to unit to unit variation 28 . Figure 4 : Hypothetical design of a multiparticulate pulsatile system 6 Andrei Dashevsky, et al. developed a pulsatile multiparticulate drug delivery system (DDS), coated with aqueous dispersion of Aquacoat® ECD. A rupturable pulsatile drug delivery system consists of (i) a drug core; (ii) a swelling layer, comprising a superdisintegrant and a binder; and (iii) an insoluble, water-permeable polymeric coating 29 . Upon water ingress, the swellable layer expands, resulting in the rupturing of outer membrane with subsequent rapid drug release. Regarding the cores, the lag time was shorter; theophylline was layered on sugar cores compared with cores consisting of theophylline. Regarding swelling layer, the release after lag time was fast and complete. Drug release was achieved after the lag time, when low-substituted hydroxypropyl cellulose (L-HPC) and sodium starch glycolate(Explotab®) were used as swelling agents. Outer membrane, formed using aqueous dispersion Aquacoat® ECD was brittle and ruptured sufficiently to ensure fast drug release, compared to ethylcellulose membrane formed using organic solution. The addition of talc led to increase brittleness of membrane and was very advantageous. Drug release starts only after rupturing of outer membrane 23 .
EVALUATION OF PULSATILE DRUG DELIVEY SYSTEM
In vitro method Dissolution studies
Dissolution studies were carried out by using USB Paddle dissolution test apparatus. Capsule were tried to paddle with a cotton thread so that the capsule should be immersed completely in dissolution media but not float. In order to stimulate the PH changes along the GIT tract, three dissolution media with PH 1.2, 7.4, and 6.8 were sequentially used, reffered to as sequential PH change method when performing experiments, the PH 1.2 Medium was first used for 2h (since the average gastric emptying time is 2h), then removed and the first PH 7.4 phosphate buffer saline (PBS) was added. After 3h (average small intestinal transit time is 3h), the medium was removed and fresh PH 6.8 Dissolution medium was added for subsequent hours. Nine hundred milliliters of the dissolution medium was used at each time. Rotation speed was 100 rpm and temperature was maintained. Capsule were tried to paddle with cotton thread in each dissolution vessel to prevent floating. Five milliliters of dissolution media was replaced. The withdrawn sample were analyzed at 296nm, by UV absorption spectroscopy and the cumulative percentage release was calculated over the sampling times 26 . Five healthy volunteers administered pellets with with 250 ml water after a 10h overnight fasting. Saliva collected at predetermined time intervals were keptfrozen at 60˚C until analytical assessment.
APPLICATION OF PULSATILE DRUG DELIVERY SYSTEM
Thorough understanding of the disease physiology is required before designing the pulsatile drug delivery system. Diseases where rhythmic circadian organization of the body plays an important role, pharmacokinetics and/or pharmacodynamics of the drugs is not constant within 24 h. .
CONCLUSIONS
There is a need of new drug delivery systems that can provide increased therapeutic benefits to the patients. Pulsatile drug delivery system (PDDS) is one such system that delivers the drug at the right time, right place and in right amounts, holds good promises of benefit to the patients suffering from chronic problems . Thus, designing of proper pulsatile drug delivery will enhances the patient compliance, optimum drug delivery to the target site and minimizes the undesired effects. PDDS can effectively tackle the problems as it is modulated according to body's circadian clock giving release of drug after a specified time lag. Significant progress has been made towards achieving pulsatile drug delivery system that can effectively treat diseases with non-constant dosing therapy.
